Literature DB >> 19489762

Functional and morphological changes in the eyes of Behçet's patients with uveitis.

Masaru Takeuchi1, Takuya Iwasaki, Takeshi Kezuka, Yoshihiko Usui, Yoko Okunuki, Jun-ichi Sakai, Hiroshi Goto.   

Abstract

PURPOSE: Behçet's disease (BD) is a chronic, recurrent, multisystem disorder, and serious ocular involvement may lead to blindness. In some BD patients, latent tissue damage caused by recurrent ocular inflammation is not reflected by visual acuity or ophthalmoscopic findings. In this study, we evaluated the morphological and functional changes of ocular features related to duration of uveitis from onset in BD patients, and analysed their association with visual acuity.
METHODS: Thirty-eight eyes of 20 patients with ocular BD were enrolled. Eyes with marked complications such as cataract, glaucoma, cystoid macular oedema, macular degeneration and optic atrophy were excluded from the study. During clinical remission of ocular inflammation, perimetric sensitivity and retinal thickness were measured by Micro Perimeter 1 (MP-1) and optical coherence tomography (OCT), respectively. The relationship between MP-1 and OCT findings, best-corrected visual acuity (BCVA) converted to logarithm of the minimum angle of resolution (logMAR) and duration from initial onset of uveitis were analysed statistically.
RESULTS: logMAR correlated with perimetric sensitivity measured with MP-1 at the fovea, inner macula and outer macula, but not with retinal thickness based on OCT. The duration of uveitis correlated significantly with logMAR and with OCT-based retinal thickness at the fovea, inner macular and outer macula, but not with MP-1-derived retinal perimetric sensitivity. No correlation was found between OCT-based retinal thickness and the corresponding MP-1-derived retinal sensitivity at the fovea, inner macula or outer macula.
CONCLUSION: These results demonstrate that visual acuity, retinal perimetric sensitivity and retinal thickness decrease with an increase in the duration of uveitis in BD patients, but that retinal perimetric sensitivity is relatively preserved among these factors.

Entities:  

Mesh:

Year:  2009        PMID: 19489762     DOI: 10.1111/j.1755-3768.2009.01536.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

Review 1.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

2.  Automated quantification of foveal avascular zone and vascular density in Behçet's disease.

Authors:  Fatih Mehmet Türkcü; Alparslan Şahin; Ümit Karaalp; Yasin Çınar; Muhammed Şahin; Zeynep Gürsel Özkurt; Uğur Keklikçi
Journal:  Ir J Med Sci       Date:  2019-07-02       Impact factor: 1.568

3.  Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.

Authors:  Umesh C S Yadav; Mohammad Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

4.  Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.

Authors:  Cheng-bo Fang; De-xi Zhou; Shu-xiang Zhan; Yong He; Zhen Lin; Cheng Huang; Jun Li
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

5.  The Effect of Infliximab Therapy on Maculopathy in Behcet's Panuveitis: A Case Report.

Authors:  Ozlem G Sahin
Journal:  Case Rep Ophthalmol       Date:  2011-12-13

6.  Correlating Photoreceptor Mosaic Structure to Clinical Findings in Stargardt Disease.

Authors:  Moataz M Razeen; Robert F Cooper; Christopher S Langlo; Mara R Goldberg; Melissa A Wilk; Dennis P Han; Thomas B Connor; Gerald A Fishman; Frederick T Collison; Yusufu N Sulai; Alfredo Dubra; Joseph Carroll; Kimberly E Stepien
Journal:  Transl Vis Sci Technol       Date:  2016-03-11       Impact factor: 3.283

7.  Neuro-Behçet, pseudotumor cerebri and ocular signs: a rare association.

Authors:  Maria Inês Rodrigues; Cláudia Loureiro; Ana Geraldo Couceiro; Cidalina Reis Ferreira; Manuel Monteiro-Grillo
Journal:  GMS Ophthalmol Cases       Date:  2013-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.